1. Developments in intravesical therapy for non-muscle-invasive bladder cancer. Issue 12 (December 2010) Authors: Lammers, Rianne JM; Witjes, J Alfred Journal: Expert review of anticancer therapy Issue: Volume 10:Issue 12(2010) Page Start: 1903 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continues. Issue 6 (June 2011) Authors: Lammers, Rianne JM; Witjes, J Alfred Journal: Expert review of anticancer therapy Issue: Volume 11:Issue 6(2011) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continues. Issue 6 (June 2011) Authors: Lammers, Rianne JM; Witjes, J Alfred Journal: Expert review of anticancer therapy Issue: Volume 11:Issue 6(2011) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continues. Issue 6 (June 2011) Authors: Lammers, Rianne JM; Witjes, J Alfred Journal: Expert review of anticancer therapy Issue: Volume 11:Issue 6(2011) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continues. Issue 6 (June 2011) Authors: Lammers, Rianne JM; Witjes, J Alfred Journal: Expert review of anticancer therapy Issue: Volume 11:Issue 6(2011) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗